Results 201 to 210 of about 789,890 (303)

Occurrence of Potential Adverse Drug Events from Prescribing Errors in a Pediatric Intensive and High Dependency Unit in Hong Kong: An Observational Study [PDF]

, 2017
Cheung, Hon Ming, Ewig, Celeste L., Kam, Kwok Ho, Knoderer, Chad A., Wong, Hiu Lam   +4 more
core   +2 more sources

Genetic pharmacoepidemiology of JAK inhibitors in chronic immune-mediated skin diseases: implications for precision therapy and medication safety. [PDF]

Front Pharmacol
Zhang Y, Qu Y, Luo Q, Liang B, Jiang Q, Zhu X, Wu J, Bao W.   +7 more
europepmc   +1 more source

Effect of Implementing a Dashboard With or Without a Best Practice Alert on HLA‐B*58:01 Testing Rates Among Allopurinol Users at VA Medical Centers

Arthritis Care &Research, EarlyView.
Objective The American College of Rheumatology recommends HLA‐B*58:01 allele testing before the initiation of allopurinol, specifically among Asian and African American/Black patients, due to their increased risk for severe hypersensitivity reactions. However, testing rates remain low at many health care facilities.
Abimbola Fadairo‐Azinge, Gabriela Schmajuk, Sristi Sharma, Colleen P. Flanagan, Sara Faghihi‐Kashani, Ning Zhang, Mary A. Whooley   +6 more
wiley   +1 more source

Nursing Students' Behavioral Intentions Toward Medication Safety: A Cross-Sectional Study Based on the Theory of Planned Behavior. [PDF]

Nurs Health Sci
Zarandona J, Labaka A, Unanue-Arza S, Lapkin S.   +3 more
europepmc   +1 more source

Medication discrepancies identified during medication reconciliation among medical patients at a tertiary care hospital

Saudi Pharmaceutical Journal, 2017
Isra Al-Rashoud, Maha Al-Ammari, Hisham Al-Jadhey, Abdulmalik Alkatheri, Gregory Poff, Tariq Aldebasi, Salah AbuRuz, Abdulkareem Al-Bekairy   +7 more
doaj   +1 more source

Enhancing medication safety engagement among older adults with diabetes and comorbidities: a quasi-experimental study protocol. [PDF]

BMJ Open
Li H, Feng Z, Zhu C, Li H, Shao L, Shao S, Du J.   +6 more
europepmc   +1 more source

Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients With Extrarenal Systemic Lupus Erythematosus—A Systematic Review and Meta‐Analysis

Arthritis Care &Research, EarlyView.
Objective Clinical response to mycophenolic acid (MPA) is highly heterogeneous; thus, therapeutic drug level monitoring (TDM) may help improve treatment efficacy. This systematic review and meta‐analysis examined therapeutic ranges for MPA levels associated with better outcomes and safety in patients with systemic lupus erythematosus (SLE ...
Zahraa Qamhieh, Dalia Sriwi, Callie Saric, Tripti Singh, Christie M. Bartels, Shivani Garg   +5 more
wiley   +1 more source

The Trial Bank initiative to promote trustworthy living evidence for medication safety (PROMISE) of children: design and pilot validation. [PDF]

BMC Med
Xu C, Doi SA, Vohra S, Furuya-Kanamori L, Wang Y, Tang L, Tian Y, Fan S, Peng Z, Mayo-Wilson E, Lin L, Chu H, Murad MH, Yu T, Li S, Chen Y, Golder S, Loke Y, Clark J, Glasziou P, Du L, Lin H, Gu Z, PROMISE Collaborative Research Network.   +23 more
europepmc   +1 more source

Building a Framework for Sexual and Reproductive Health Care in the Rheumatology Context: Content and Approaches

Arthritis Care &Research, EarlyView.
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley   +1 more source

Towards interprofessional medication safety risk management: a qualitative interview study for physicians in primary and secondary care. [PDF]

BMJ Open
Saavalainen A, Sirenius H, Linden-Lahti C, Laukkanen E, Hosia H, Holmström AR.   +5 more
europepmc   +1 more source